Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of omalizumab in Aspergillus-associated airway disease.
Pérez-de-Llano LA, Vennera MC, Parra A, Guallar J, Marin M, Asensio O, Ausin P, Borderías L, Fernández C, Granel C, Pérez-Pimiento A, Rubio M. Pérez-de-Llano LA, et al. Thorax. 2011 Jun;66(6):539-40. doi: 10.1136/thx.2010.153312. Epub 2011 Mar 11. Thorax. 2011. PMID: 21398373 No abstract available.
Omalizumab therapy in severe asthma: experience from the Spanish registry--some new approaches.
Vennera Mdel C, Pérez De Llano L, Bardagí S, Ausin P, Sanjuas C, González H, Gullón JA, Martínez-Moragón E, Carretero JA, Vera E, Medina JF, Alvarez FJ, Entrenas LM, Padilla A, Irigaray R, Picado C; Spanish Registry. Vennera Mdel C, et al. J Asthma. 2012 May;49(4):416-22. doi: 10.3109/02770903.2012.668255. Epub 2012 Mar 23. J Asthma. 2012. PMID: 22443408
Clinical audit of COPD patients requiring hospital admissions in Spain: AUDIPOC study.
Pozo-Rodríguez F, López-Campos JL, Alvarez-Martínez CJ, Castro-Acosta A, Agüero R, Hueto J, Hernández-Hernández J, Barrón M, Abraira V, Forte A, Sanchez Nieto JM, Lopez-Gabaldón E, Cosío BG, Agustí A; AUDIPOC Study Group. Pozo-Rodríguez F, et al. PLoS One. 2012;7(7):e42156. doi: 10.1371/journal.pone.0042156. Epub 2012 Jul 31. PLoS One. 2012. PMID: 22911875 Free PMC article.
What pulmonologists think about the asthma-COPD overlap syndrome.
Miravitlles M, Alcázar B, Alvarez FJ, Bazús T, Calle M, Casanova C, Cisneros C, de-Torres JP, Entrenas LM, Esteban C, García-Sidro P, Cosio BG, Huerta A, Iriberri M, Izquierdo JL, López-Viña A, López-Campos JL, Martínez-Moragón E, Pérez de Llano L, Perpiñá M, Ros JA, Serrano J, Soler-Cataluña JJ, Torrego A, Urrutia I, Plaza V. Miravitlles M, et al. Int J Chron Obstruct Pulmon Dis. 2015 Jul 15;10:1321-30. doi: 10.2147/COPD.S88667. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26270415 Free PMC article.
A Simple Score for Future Risk Prediction in Patients with Controlled Asthma Who Undergo a Guidelines-Based Step-Down Strategy.
Pérez de Llano L, García-Rivero JL, Urrutia I, Martínez-Moragón E, Ramos J, Cebollero P, Carballada F, Blanco-Aparicio M, Vennera MDC, Merino M, Torralba-García Y, Plaza V. Pérez de Llano L, et al. J Allergy Clin Immunol Pract. 2019 Apr;7(4):1214-1221.e3. doi: 10.1016/j.jaip.2018.10.017. Epub 2018 Oct 25. J Allergy Clin Immunol Pract. 2019. PMID: 30368006
Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score.
Pérez de Llano L, Dávila I, Martínez-Moragón E, Domínguez-Ortega J, Almonacid C, Colás C, García-Rivero JL, Carmona L, García de Yébenes MJ, Cosío BG; FEOS Study Group. Pérez de Llano L, et al. J Allergy Clin Immunol Pract. 2021 Jul;9(7):2725-2731. doi: 10.1016/j.jaip.2021.01.033. Epub 2021 Feb 4. J Allergy Clin Immunol Pract. 2021. PMID: 33549843
Guidelines for severe uncontrolled asthma.
Cisneros Serrano C, Melero Moreno C, Almonacid Sánchez C, Perpiñá Tordera M, Picado Valles C, Martínez Moragón E, Pérez de Llano L, Soto Campos JG, Urrutia Landa I, García Hernández G. Cisneros Serrano C, et al. Arch Bronconeumol. 2015 May;51(5):235-46. doi: 10.1016/j.arbres.2014.12.007. Epub 2015 Feb 10. Arch Bronconeumol. 2015. PMID: 25677358 English, Spanish.
The Response to Biologics is Better in Patients with Severe Asthma Than in Patients with Asthma-COPD Overlap Syndrome.
Pérez de Llano L, Dacal Rivas D, Marina Malanda N, Plaza Moral V, Gullón Blanco JA, Muñoz-Esquerre M, García-Moguel I, Díaz Campos RM, Martínez-Moragón E, Harbenau Mena A, Cosío BG, Padilla Galo A, Cisneros Serrano C. Pérez de Llano L, et al. J Asthma Allergy. 2022 Mar 18;15:363-369. doi: 10.2147/JAA.S338467. eCollection 2022. J Asthma Allergy. 2022. PMID: 35330786 Free PMC article.
Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study.
Pérez de Llano LA, Cosío BG, Domingo C, Urrutia I, Bobolea I, Valero A, Entrenas Costa LM, Quirce S, Barranco P, Marina Malanda N, Andrés LP, Alvarez-Gutiérrez FJ. Pérez de Llano LA, et al. J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2277-2283.e2. doi: 10.1016/j.jaip.2019.01.017. Epub 2019 Jan 21. J Allergy Clin Immunol Pract. 2019. PMID: 30677539 Free article. Clinical Trial.
129 results